BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32357402)

  • 1. Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A
    Zhao L; Jin W; Cruz JG; Marasini N; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
    Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32357402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
    Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
    ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
    Zhao L; Yang J; Nahar UJ; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
    Bioorg Med Chem; 2020 Dec; 28(24):115823. PubMed ID: 33120079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A
    Kiong J; Nahar UJ; Jin S; Shalash AO; Zhang J; Koirala P; Khalil ZG; Capon RJ; Skwarczynski M; Toth I; Hussein WM
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
    Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.
    Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
    Eur J Med Chem; 2019 Oct; 179():100-108. PubMed ID: 31247372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Trimethyl Chitosan-Based Polyelectrolyte Complexes for Peptide Subunit Vaccine Delivery.
    Zhao L; Bashiri S; Toth I; Skwarczynski M
    Methods Mol Biol; 2022; 2414():141-149. PubMed ID: 34784036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus.
    Marasini N; Ghaffar KA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Curr Drug Deliv; 2017; 14(5):701-708. PubMed ID: 27440071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A
    Dai CC; Yang J; Hussein WM; Zhao L; Wang X; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
    ACS Infect Dis; 2020 Sep; 6(9):2502-2512. PubMed ID: 32786276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
    Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus.
    Yang J; Firdaus F; Azuar A; Khalil ZG; Marasini N; Capon RJ; Hussein WM; Toth I; Skwarczynski M
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of trimethyl chitosan and poly(anionic amino acid)-peptide antigen conjugate to produce a potent self-adjuvanting nanovaccine delivery system.
    Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
    Bioorg Med Chem; 2019 Jul; 27(14):3082-3088. PubMed ID: 31176567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines.
    Yang J; Boer JC; Khongkow M; Phunpee S; Khalil ZG; Bashiri S; Deceneux C; Goodchild G; Hussein WM; Capon RJ; Ruktanonchai U; Plebanski M; Toth I; Skwarczynski M
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.
    Marasini N; Giddam AK; Khalil ZG; Hussein WM; Capon RJ; Batzloff MR; Good MF; Toth I; Skwarczynski M
    Nanomedicine (Lond); 2016 Dec; 11(24):3223-3235. PubMed ID: 27830630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.
    Marasini N; Giddam AK; Ghaffar KA; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Nanomedicine (Lond); 2016 May; 11(10):1223-36. PubMed ID: 27077314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
    Ghaffar KA; Marasini N; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2016 Sep; 41():161-8. PubMed ID: 27063491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyelectrolyte-Based Platforms for the Delivery of Peptides and Proteins.
    Zhao L; Skwarczynski M; Toth I
    ACS Biomater Sci Eng; 2019 Oct; 5(10):4937-4950. PubMed ID: 33455241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.